A B S T R A C T To evaluate the effects of glucocorticoids on the Na-K pump in human subjects, we evaluated the intracellular sodium and potassium, 42K influx across and the [3H]ouabain binding to cell membranes of intact human erythrocytes from a group of subjects taking glucocorticoids and a group of normal subjects. Intracellular sodium concentration was lower (7.2±0.4 vs. 10.9+0.2 mmol/liter cell water) and intracellular potassium concentration higher (149.8± 1.5 vs. 137.2±1.2 mmol/liter cell water) in erythrocytes from steroid-treated patients. In spite of a significantly decreased intracellular sodium which normally diminishes ouabain-sensitive 42K influx, the ouabain-sensitive K influx was unchanged in erythrocytes from the steroid-treated group. Maximum [3H]ouabain binding was markedly higher in the steroid-treated group (835±44 vs. 449±11 sites/cell). There was close linear correlation between [3H]ouabain binding and inhibition of K pump, suggesting the specificity of ouabain binding to Na-K pump sites on the cell membrane. Association kinetics for ouabain were similar in the two groups despite the marked difference in the amount of [3H]ouabain binding. External potassium concentration required for half-maximum ouabain-sensitive K influx was identical in the two groups. Thus, the additional Na-K pump sites in the steroid-treated group were qualitatively similar to those in normals. These results suggest that administration of glucocorticoids leads to an increase in the number of Na-K pump sites. The increase in the number of Na-K pump sites may explain the low levels of intracellular sodium and higher cell potassium observed in steroid-treated subjects.
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INTRODUCTION
A large body of evidence supports the concept that the intracellular concentration of sodium and potassium and the transcellular movement of these monovalent cations are influenced by a specific transport system, consisting of an ATPase and usually referred to as the sodium potassium pump (1) (2) (3) . Glucocorticoids have been shown to increase Na-K ATPase activity in the rat kidney (4, 5) and more recently in the small and large intestine (6) . Erythrocytes from two patients with Cushing's syndrome have also been reported to show increased Na-K ATPase activity (7) but the effects of glucocorticoids on the Na-K pump in human subjects have not been extensively investigated.
The present studies were designed to evaluate the influence of glucocorticoids on the Na-K pump of erythrocytes from human subjects. Previous investigators have used [3H] ouabain to quantitate the number of Na-K pump sites on various cell types in the healthy state (8) (9) (10) . The use of this radioligand permitted us to quantitate the number of Na-K pump sites on human erythrocytes and to correlate changes in the number of Na-K pump sites with observed alterations in intracellular electrolytes and potassium flux across cell membranes. The human erythrocyte was chosen because ofits known contribution to the elucidation of the normal physiology of the Na-K pump and its easy accessibility in human subjects. Our results indicate a consistent and marked alteration in the Na-K pump of human erythrocytes following the administration of glucocorticoid hormones.
METHODS

Subjects
Subjects were divided into two categories.
drugs. Their ages ranged from 29 to 44 yr (mean age, 36 yr).
Group II. Steroid-treated group. This group consisted of 17 patients, 15 males and 2 females. Their ages ranged from 28 to 82 yr (mean age, 48 yr). Subjects in the steroidtreated group were selected for inclusion in the study if they were receiving 20 mg/d prednisone (or other glucocorticoids with its equivalent dose) for 4 wk or more and if cardiac glycosides were not administered in the week before the study. Blood transfusion within 8 wk before the study was an indication for exclusion. Six subjects were studied before and during glucocorticoid administration. 
Solution and chemicals
Preparatiotn of erythrocyte suspensionis
Fresh heparinized blood was cenitrifugedv withiin 1 h of collection. The plasma, buffy coat, and the topmost layer (= 10%) ofthe erythrocytes were discarded, and the remaining erythrocytes were resuspended in ice-cold isotonic magnesium chloride, pH 7.4. During each of the three washes that followed, the supernataint MgCl., anid the topmost layer of erythrocytes were discarded. The precise hematocrit of the washed erythrocyte suspension was determiined in triplicate.
Measuremetnt of erythrocyte cation co ncenttrations
The method used was that of Smith anid Samuels (11) . The erythrocyte suspension of known hematocrit and volume (usually 0.5 ml) was lysed, diluted with lithium diluent, and the cation contents determined with a flame photometer (Instrumentation Laboratory Inc., Lexington, Mass.) and calculated as millimiioles per liter of erythrocytes. The volume 'Abbreviation used in this paper: Na-T-G solution, 130 mM NaCl, 10 mM glucose, 10 mM Tris HCI, and 20 mM sucrose, pH 7.45. fraction of water was calculated from wet and drv weights of cell suspension and specific gravity using the relation published previouslyr (12) . Cation concentrationis were calculated and expressed as millimoles per liter cell water.
Measuremnent of K inlflux
The method used was that of Sachs and Welt (13) . Cells were suspended at 2-4% hemiatocrit in Na-T-G solution containing 42K and 10 mnM KCI for 45 min. The reaction was stopped by adding 10 ml of ice-cold isotoniC MgCl2 to the cell suspenision. The cells were washed three times at 4°C by alternate centrifugationi and resuspenisioni in isotonic MgCI2. Radioactivities of cell suspensionis and incubation media were dletermiinledl with a gammllla counter (Beekman Instrumenits, Inc.). Similar experimenits wvere carried out in the presence of 0.5 mn.M ouiabain to miieasure ouiabain-insensitive K inifluix. Ouabain-sensitive 42K in flux wvas calculated as the difference between total and ouabain-insensitive flux. Ouabainsenisitive K influx was measured at various external K concenitrattionis from 0.25 to 10 mmilol/liter anid the conicentrationi of externcal potassiumiii required for half-mlaximiial pUmllp influx was dletermiinied.
Measuremenit of [3H]ouabain bitnditng
The method used was that of Joiner and Lauf (14) . Prewarmed [3H]ouabain was added to a 0.2-ml cell suspension in 2 ml of K-free Na-T-G solution at 37°C to give a final concentrationi of 0.1 tMNI [3H]ouabain. Studies were performed at least in duplicate and in addition, one study) was always performed in the presenice of unllabeled outabain at a concenitration of 0.1 mMN or more. Maximum ouabain binding was meassured after 3 h of incubation, at which time 0.5-ml aliquots were transferred to a tube containinig 9 ml of isotonlic ice-cold MgCl2, pH 7.45, over 2 ml of dibuty'lphthalate. Upon centrifugation, cells with bound radioactivity settled beneath the organic layer, whereas unbound ouabain remainied in the aqueous phase. The aqueous layer was aspirated and traces of [3H]ouabain remiiaining at the side of the tube were remloved by' carefully' pouring fresh MgCl2 up to the brimn and aspiratiing the MgCl2 layer. After aspiratinig both the organic and aqueous layers, the cells were hemolyzed in icecold 10 (15) . Erythrocyte glucose-6-phosphate dehydrogenase was measured by the change in optical density at 340 nM due to NADP reduction using the Sigma test kit. Reticulocytes were stained with a methylene blue stain (Sigma Chemical Co.) and counted with at least 1,000 erythrocytes.
RESULTS
The clinical data for the steroid-treated group are summarized in Table I .
Intracellular cation concentrations ( Fig. 1 ). Intracellular sodium and potassium concentrations in the normal group were 10.9±0.23 and 137.2±1.2 mmol/ liter cell water, respectively ( Fig. 1 ). Intracellular sodium was 7.2 ±0.4 mmol/liter cell water in the steroid-treated group, significantly decreased as compared with normals (P < 0.001). Intracellular potassium was 149.8 ±1.5 mmol/liter cell water, significantly increased as compared with the normal group (P < 0.001). Water content was identical (0.7 liter/liter cells) in both groups.
K influx (Table II) . K influx was measured in 10 subjects from the steroid-treated group and 10 subjects from the normal group. The mean intracellular sodium concentrations in these 10 subjects from groups I and II were 11.1±0.56 and 7.4+±0.46 mmol/liter cell water, respectively, similar to the averages for the entire group. Several groups of investigators have shown that an increase in intracellular sodium concentration increases, and a decrease in intracellular sodium concentration decreases ouabain-sensitive K influx (K pump influx) (16) (17) (18) (19) . However, in spite of a significantly lower intracellular sodium concentration in the steroid-treated group, K pump influx was the same as that found in the normal group (Table II half-maximal binding was established within -10 min in both groups and binding was essentially complete at 60 min in each and every subject in either group (Fig. 3, top panel) . The interaction of ouabain with its receptor on the Na-K pump could be described by the second order reaction.
where Ou stands for free ouabain, B stands for free ouabain binding sites, Ou B stands for bound ouabain. Ou B is relatively stable, since its dissociation rate is very slow (10) . Thus, the velocity of ouabain binding was given by the relation,
where a = initial concentration of free ouabain, b = initial concentration of free ouabain binding sites, x = concentration of bound ouabain, and t = time in minutes. The association rate constant kb was given by integrating and rearranging (2).
plotted against time was linear in both groups. The line for the normal group was y = -0.01 + 0.07 x, r2 = 0.94 and that for the steroid-treated group was y = +0.01 + 0.07 x, r2 = 0.89. The two lines were not significantly different. The association rate constant kb given by the slope of the plots was 0.07 x 107/mol per min in both groups, indicating that the affinity of ouabain for its receptor on the Na-K pump was unchanged in the erythrocytes from the glucocorticoid-treated group in spite of the increase in the total number of Na-K pump sites in the latter group. Thus, the principal feature of the [3H]ouabain binding studies was a marked increase in the total number of ouabain binding sites in the erythrocytes from the glucocorticoid-treated group; in other respects the receptor for ouabain was qualitatively identical to the one found in normal subjects.
Correlation 3) was subtracted from the total pump influx (uninhibited) present before addition of [3H]ouabain at time zero (Fig. 3 ) to obtain the degree of inhibition of K pump influx. Fig. 4 plots the percent inhibition of K pump influx against the fractional occupancy of [3H]-ouabain binding sites. The plots were linear in both groups. The linearity of plot in normal subjects confirmed earlier observations of the one-to-one relationship between ouabain molecules bound and Na-K pump sites (10) . The linearity of plot in the glucocorticoid-treated group provided evidence for the specificity of [3H]ouabain binding in representing additional Na-K pump sites. (20) . Extensive and elegant investigations have been carried out to define various cellular and subcellular mechanisms of action of glucocorticoid hormones (21) . However, relatively little information is available on the effect of glucocorticoids on the Na-K pump in human subjects. In view of the importance of this active pump mechanism in modulating renal and extrarenal transport of potassium and sodium in health and various disease states, we undertook a detailed examination of the effects of exogenous glucocorticoids on the Na-K pump of the human erythrocytes.
An alteration in the activity of the Na-K pump is often reflected by a change in the intracellular concentration of sodium. Thus, in the uremic state and in subjects taking digoxin, a decrease in the activity of the Na-K pump is reflected by an increase in the intracellular sodium concentration (22, 23) . Conversely, our initial findings of decreased intracellular sodium concentration and increased intracellular potassium concentration in erythrocytes from the steroid-treated group (Fig. 1 ) strongly suggest that the activity of the Na-K pump was enhanced. A less attractive possibility is that the reciprocal changes in the intracellular cation concentrations were the result of a simultaneous decrease in the passive permeability of the cell membranes to both sodium and potassium without any significant alteration in Na-K pump activity.
Several groups of investigators have shown that changes in the intracellular concentration of sodium have a direct and almost linear correlation with K pump influx (16) (17) (18) (19) . Thus, a decrease in intracellular sodium, such as that observed in the steroid-treated group, would be expected to lower K pump influx as compared with normals. However, K pump influx was unchanged in the steroid-treated group despite lower intracellular sodium (Table II) , suggesting that K pump influx would be higher in the steroid-treated group when measured under conditions where the internal ionic milieu were comparable in the two groups. The lack ofdiminution in K pump influx in spite of lower intracellular sodium concentration provides additional evidence of enhanced activity of the Na-K pump in erythrocytes from the steroid-treated group. The finding of an increase in ouabain-insensitive K influx is in keeping with the concept of pump-leak interdependence and is somewhat analogous to other disease states such as hereditary spherocytosis, hereditary stomatocytosis, and in Rh null cells in which similar, concomitant changes in the pump activity and passive fluxes were observed (24) (25) (26) .
To determine whether increased activity of the Na-K 428 (28, 29) . However, the reticulocyte count in our steroid-treated patients was not elevated. Younger cells and reticulocytes have higher activities of erythrocyte glucose-6-phosphate dehydrogenase and glutamate oxaloacetate transaminase (30, 31) , whereas the activities of these enzymes were not significantly higher in erythrocytes from steroid-treated patients. There was no correlation between ouabain binding and erythrocyte enzyme levels, indicating that the higher ouabain binding obtained in the steroid-treated group was not due to a younger cell population. Furthermore, younger cells have significantly lower density, higher water content, and lower mean hemoglobin concentration (28, (32) (33) (34) .
Density, water content, and mean hemoglobin concentration were almost identical in the cells from normal and steroid-treated groups. Thus, the observations reported here cannot be attributed to a difference in the age of cells in the two groups, but must be due to other direct effects of glucocorticosteroids on the erythrocytes. Since there was no difference in the morphology of the cells in the two groups and mean corpuscular volume was only sightly higher in the steroidtreated group (89.1 fl as compared with 87.5 fl in the normal group), it is safe to assume that differences in surface area could not account for the increase in [3H]-ouabain binding. Thus (Fig. 4) . Thus, the correlation between ouabain binding and the inhibition of K pump influx in both groups was independent of both the time of incubation and the concentration of ouabain used. These findings are similar to those reported earlier by other workers for ouabain binding in normal subjects (10) and strongly suggest that ouabain binding was specific for the Na-K pump sites in erythrocytes from the steroid-treated group as well as normals. In addition, the linearity of the plot (Fig. 4) suggests that all the pump sites in the glucocorticoid group were functionally homogenous with respect to K pump influx. Using the equation for second order reactions, we calculated the association rate constant (kb) for the association of ouabain to its binding site in normal subjects and patients from the steroid-treated group. Our finding of similar association rate for the steroid-treated group taken together with the finding of similar K0.5 for K influx with respect to external potassium suggests that the ouabain binding and the Na-K pump were qualitatively similar in the two groups and that no conformational change was detectable in the Na-K pump in the steroid group using the methods described.
It is currently believed that glucocorticoids act at the transcriptional or post-transcriptional stage to derepress the genome, allowing RNA translation and protein synthesis to proceed in the nucleus (20) . Since the circulating, mature erythrocyte is enucleate and does not synthesize protein and RNA, it is most likely that the observed alterations in the Na-K pump occurred during the course of erythropoiesis and were primarily directed at the nucleated precursor cells. The observation of a long lag period between the initiation of glucocorticoid administration and the attainment of peak values of [3H]ouabain binding sites is in agreement with this proposal (Fig. 5) . In addition, the alternative but less likely possibility that glucocorticoids act on the mature erythrocyte is not supported by our failure to induce changes in [3H]ouabain binding or net sodium or potassium flux in erythrocytes and ghosts during in vitro incubation in a bath containing methylprednisolone.
Thus, our results indicate that administration of glucocorticoids in pharmacologic doses, given for a wide variety ofclinical disorders, consistently results in an increase in the surface density of Na-K pumps on human erythrocytes, an increase in intracellular potassium, and a decrease in intracellular sodium concentration. Our working hypothesis for the observed alterations in Na-K pump invokes an increase in the number of Na-K pump sites as the primary event, with the consequent increase in pump activity resulting in active sodium extrusion up to a point where the lowering of intracellular sodium decreased sodium efflux and potassium influx back to the original steady-state values, albeit in the face of lower intracellular sodium concentration. The finding that increase in [3H]ouabain binding preceded changes in intracellular electrolytes (Fig. 5 ) supports this construct. These findings are consistent with earlier observations of an increase in Na-K ATPase in the rat kidney following the administration of glucocorticoids (4) and extend these observations in human subjects. The present data do not allow us to exclude the possibility that these observations may be explained by occupancy of mineralocorticoid receptors by pharmacological doses of glucocorticoids (35) . In this context, it is of interest to note that both dexamethasone and aldosterone have been shown to restore Na-K ATPase in adrenalectomized rats but the doses of aldosterone required to restore Na-K ATPase levels in earlier experiments were supermaximal with respect to mineralocorticoid action, leading to the inference that the increase in Na-K ATPase was the result of occupancy of glucocorticoid receptors by aldosterone (4, 36) .
Cole and Maletz (37) reported decreased erythrocyte sodium and increased Na-K ATPase in renal transplant recipients, and observed that the changes were the obverse of those reported in uremia. In light of the findings presented here, it appears likely that the findings described in transplant recipients were, in large part, due to the administration of prednisone in those patients. Conventionally, glucocorticoids are thought to have little or no influence on the transport of sodium or potassium in the kidney or the gut. Our finding of consistent and major alterations of the Na-K pump in human erythrocytes during glucocorticoid administration suggests the need to further define a more precise role of glucocorticoids in modulating electrolyte transport in man.
